farnaz shokraneh | personalized medicine | Best Researcher Award

Posted on by ScienceFather

Ms. farnaz shokraneh | personalized medicine | Best Researcher Award

Abo Akademi University, Finland

👨‍🎓Professional Profile 

Orcid Profile

👩‍🔬 Summary

Ms. Farnaz Shokraneh is an experienced pharmaceutical professional currently working as a Doctoral Researcher in Pharmaceutical Development and Medical Technology at Åbo Akademi University in Turku, Finland. With a solid academic background and extensive practical experience in pharmaceutical quality assurance, regulatory compliance, and research, she brings valuable insights into the development of pharmaceutical products and systems. She is committed to advancing personalized medicine and improving quality control in the pharmaceutical industry.

🎓 Education

Ms. Shokraneh holds a Doctor of Pharmacy degree, equivalent to a Finnish Master’s, from Islamic Azad University, Tehran, Iran (2007-2012). She furthered her academic journey with a Master’s in Pharmaceutical Research from Freie Universität Berlin, Germany (2022-2024). Currently, she is pursuing her doctoral research in Pharmaceutical Development and Medical Technology at Åbo Akademi University, Turku, Finland (2022–present).

💼 Professional Experience

Ms. Shokraneh has accumulated extensive experience in various roles within the pharmaceutical industry. She is currently serving as a Quality Manager at CurifyLabs Oy in Helsinki, Finland, since September 2022. Previously, she held the position of Quality Assurance Manager at Mofid Pharma under the license of Bayer Pharmaceutical Company (Dec 2020–Dec 2021). Additionally, she has worked at Modava Pharmaceutical under Novartis (Jul 2018–Jul 2020) and ATI Pharmed Pharmaceutical Co under StragenPharma and CHEMO Pharmaceutical licenses (Apr 2013–Jun 2017).

🛠️ Technical Skills

Ms. Shokraneh’s technical expertise encompasses pharmaceutical development, quality assurance, and regulatory compliance. She is proficient in analytical techniques such as HPLC, mass spectrometry, and micro NIR spectrophotometry. Her experience also extends to pharmacovigilance, safety monitoring, and statistical analysis for pharmaceutical applications, making her highly skilled in ensuring the safety, efficacy, and quality of pharmaceutical products.

🧑‍🏫 Teaching Experience

Although Ms. Shokraneh’s current focus is on research and industry roles, her vast knowledge and experience in the pharmaceutical field allow her to effectively mentor teams and share her expertise. She has contributed to the professional development of her colleagues and participated in educational training programs within the pharmaceutical sector.

🔬 Research Interests

Ms. Shokraneh’s primary research interests lie in pharmaceutical development and medical technology, with a particular focus on personalized medicine. She is passionate about improving drug safety and efficacy through innovations in automated pharmacy compounding, quality control, and exploring new methods for drug delivery and patient-specific treatment plans.

 

📖Top Noted Publications

Automated Non-Sterile Pharmacy Compounding: A Multi-Site Study in European Hospital and Community Pharmacies with Pediatric Immediate Release Propranolol Hydrochloride Tablets

Authors: Niklas Sandler Topelius, Farnaz Shokraneh, Mahsa Bahman, Julius Lahtinen, Niko Hassinen, Sari Airaksinen, Soumya Verma, Ludmila Hrizanovska, Jana Lass, Urve Paaver et al.

Journal: Pharmaceutics

Year: 2024

A Novel High Performance Liquid Chromatographic Method for Determination of Nystatin in Pharmaceutical Formulations by Box–Behnken Statistical Experiment Design

Authors: Farnaz Shokraneh

Journal: Iranian Journal of Pharmaceutical Research

Year: 2014

Comparative Studies of Cytotoxic Manufacturing Practices in Specialized Cancer Centers Against International Guidelines (ASHP, OSHA, HSE-UK)

Authors: Farnaz Shokraneh

Journal: FIP Congress

Year: 2012

Development and Validation of High-Performance Liquid Chromatography for Determination of Nystatin in Pharmaceutical Formulations

Authors: Farnaz Shokraneh

Journal: Research in Pharmaceutical Science

Year: 2012

A New HPLC Method for Determination of Losartan in Human Plasma and Its Application in Bioequivalence Studies

Authors: Farnaz Shokraneh

Journal: Oriental Journal of Chemistry

Year: 2012

Risks to Health Professionals from Hazardous Drugs in Iran: A Pilot Study of Understanding of Healthcare Team to Occupational Exposure to Cytotoxics

Authors: Farnaz Shokraneh

Journal: EXCLI Journal

Year: 2005

Yishay Manassen – Emerging Research Trends – Excellence in Innovation 

Posted on by ScienceFather

Prof Yishay Manassen - Emerging Research Trends - Excellence in Innovation 

Dept of physics, Ben Gurion University, Beer Sheva  - Israel

Author Profile

Early Academic Pursuits

Prof Yishay Manassen embarked on his academic journey with a Ph.D. in magnetic resonance (NMR) at Tel Aviv University. This laid the foundation for his expertise in the field.

Professional Endeavors

Following his doctoral studies, Prof Manassen pursued a Post Doc at IBM TJ Watson in Yorktown Heights, NY, where he initiated work with Scanning Tunneling Microscopy (STM) in collaboration with J Demuth. Subsequently, he joined the Weizmann Institute in Rehovot before settling at Ben Gurion University, where he currently serves as a Full Professor in the Physics Department.

Contributions and Research Focus

Prof Manassen's groundbreaking work includes being the first to demonstrate single spin detection with STM (ESR-STM), along with other significant contributions to STM studies. Over the years, he showcased the feasibility of ESR-STM on diamagnetic molecules, unraveling the mechanism of ESR-STM. Notably, he demonstrated the use of ESR-STM for single-atom NMR, showcasing its potential applications in physics and medicine.

Accolades and Recognition

His illustrious career is marked by achievements such as being the first to achieve single spin detection with STM and demonstrating innovative applications of ESR-STM in various molecular scenarios. His work has been recognized with two awards, contributing to his citation index of 65.

Impact and Influence

With over 35 years of experience, Prof Manassen's impact on the field of physics is evident. His work on STM and single atom magnetic resonance has opened new avenues for research, particularly in studying superconductors and medical applications.

Legacy and Future Contributions

Prof Manassen's legacy includes significant advancements in magnetic resonance and STM. His recent breakthroughs in STM-NMR showcase a promising future for diverse applications, offering insights into the identification of different atoms. His work is expected to continue influencing physics and medical research.

This comprehensive profile reflects Prof  Yishay Manassen's academic journey, his substantial contributions to magnetic resonance and STM, and the enduring impact of his research in the scientific community.

Notable Publication